{"database": "lobbying", "table": "lobbying_activities", "rows": [[2861518, "059eb52b-fb9a-442c-a2e9-1f85eb811139", "Q3", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2022, "third_quarter", "MMM", "PL 117-169 - The Inflation Reduction Act - Support for policies delaying the Trump-era Rebate Rule. S. 3700 - The INSULIN Act - Issues related to making insulin affordable for all Americans. Regulations focused on quality measures used in contracting relationships between pharmacy benefit managers and pharmacies (known as DIR). PL 117-2 - The American Rescue Plan Act - Implementation of policies related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2022-10-08T09:40:46-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2861518"], "units": {}, "query_ms": 1.4985959278419614, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}